1Florida Alzheimer's Disease Research Center Research Education Core

1佛罗里达阿尔茨海默病研究中心研究教育核心

• 批准号: 9921608
• 负责人: GLENN E. SMITH
• 金额: $ 16.72万
• 依托单位: UNIVERSITY OF FLORIDA
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-06-15 至 2025-04-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/9921608
• 关键词: Active Learning; Alzheimer' s Disease; Caring; Clinical; Clinical Sciences; Collaborations; Communication; Communities; Competence; Development; Discipline; Disease; Educational Curriculum; Effectiveness; Engineering; Ethnic Origin; Evaluation; Faculty; Florida; Funding; Future; Gender; Goals; Government; Health Occupations; Health Sciences; Immersion; Infrastructure; Institutes; Leadership; Learning; Medicine; Mentors; Mind; Molecular Biology; NCI Scholars Program; Neurological Nursing; Neurology; Pharmacy facility; Population Sciences; Positioning Attribute; Postdoctoral Fellow; Private Sector; Process; Program Development; Psychology; Public Health; Research; Research Personnel; Research Training; Role; Science; Science Policy; Scientist; Site; Training; Translational Research; Universities; Veterinary Medicine; Work; base; career; career development; cohort; computer science; data management; disorder prevention; education research; experience; health equity; implementation science; innovation; interest; leadership development; multidisciplinary; next generation; peer coaching; peer support; programs; recruit; research and development; science education; science teacher; skills; success; translational scientist

The primary goal of the 1Florida ADRC Alzheimer’s Science Training to Advance Research Success (1FL AlzSTARS) program is to train diverse, multidisciplinary Early Stage Investigators (ESIs). Junior faculty or research associates from across the 1Florida ADRC consortium will be trained for leadership roles in research translation especially with regards to diverse and underserved communities. Our premises for developing the 1FL AlzSTARS program include the understanding that AD and AD related disorders (AD+ADRD) researchers from diverse disciplines 1) need a set of core competencies to contribute to the continually evolving field of 2) should be trained in leadership and team science, 3) must understand concepts ranging from molecular biology to population and implementation science 4) should be prepared to work in variety of settings and 5) should be trained within a cohort of like-minded ESIs. The 1FL AlzSTARS program therefore has three aims summarized as: 1) recruit and train a cohort of ten highly qualified ESIs 2) deliver an innovative, collaborative, multi-institutional two-year program of coursework and mentored research experience 3) evaluate the impact of the 1FL AlzSTARS program. Our scholars will be diverse with regard to gender, ethnicity, SES, discipline, consortium site, translational research interests, and career plans, and disposed to study diversity and disparity factors. The program will synthesize mentored research and professional development experiences with three formal didactic foci i) AD+ADRD specific curriculum, ii) health equity curriculum, iii) general C/T research curriculum. The University of Florida and University of Miami Clinical and Translational Science Institutes (CTSIs) have created programs to support the transition of a range of professionals to independent investigators (e.g. K-to-R programs) and to continue their development as mentors and leaders in their fields. The 1FL AlzSTARS program will provide a critical conduit to focus these CTSIs’ successes towards the development of clinician-scientists and basic scientists desiring translational research careers in AD+ADRD. Finally we will deploy a careful evaluation process to assess 1FL AlzSTARS program impacts including completion of didactic and experiential learning opportunities, mastery of core competencies and best research practices, and most importantly scholar’s career trajectories, advancement, and retention.

佛罗里达州ADRC阿尔茨海默氏症科学培训的主要目标是推进研究成功（1FL AlzSTARS）计划是培养多样化，多学科的早期研究人员（ESI）。初级教员或 来自佛罗里达州ADRC联盟的研究助理将接受研究领导角色的培训 翻译，特别是关于多样化和服务不足的社区。我们的发展前提 1FL AlzSTARS计划包括了解AD和AD相关疾病（AD+ADRD）研究人员 1）需要一套核心能力，以促进不断发展的领域2） 应接受领导力和团队科学方面的培训，3）必须了解从分子到分子的概念 生物学到人口和实施科学4）应该准备在各种环境中工作，5） 应该在一群志同道合的ESI中接受培训。因此，1FL AlzSTARS计划有三个目标 概括为：1）招募和培训一批10名高素质的ESI 2）提供一个创新的， 合作，多机构的课程和指导研究经验的两年计划3） 评估1FL AlzSTARS计划的影响。我们的学者将在性别方面多样化， 种族，SES，学科，联盟网站，翻译研究兴趣和职业规划，并倾向于 研究多样性和差异因素。该计划将综合指导研究和专业 三个正式教学重点的发展经验i）AD+ADRD具体课程，ii）健康公平 课程，iii）一般C/T研究课程。佛罗里达大学和迈阿密大学临床和 转化科学研究所（CTSIs）已经创建了一些项目，以支持一系列 从专业人员到独立调查人员（例如K-to-R计划），并继续发展， 导师和领导者在他们的领域。1FL AlzSTARS计划将提供一个关键渠道， CTSIs在临床科学家和基础科学家发展方面的成功， AD+ADRD的研究生涯。最后，我们将部署一个仔细的评估过程，以评估1FL AlzSTARS 计划的影响，包括完成教学和体验式学习的机会，掌握核心 能力和最佳研究实践，最重要的是学者的职业轨迹，进步， 和保留。